FAST (Fluid Accumulation Status Trial)
Public ClinicalTrials.gov record NCT00289276. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. Using very low electrical pulses that travel across the inside of the chest cavity, thoracic fluid status monitoring (OptiVol™) can measure the level of resistance to the electrical pulses, which indicates the level of fluid in the chest. The purpose of this study is to collect information related to fluid build up in the chest of subjects with heart failure.
Study identification
- NCT ID
- NCT00289276
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 156 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2003 (Type not available)
- Primary completion
- Apr 2008 (Actual)
- Completion
- Not listed
- Last update posted
- Oct 13, 2010
Started 2003
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Cardiovascular Research Foundation | Anchorage | Alaska | 99508 | — |
| Palm Beach Heart Institute | Atlantis | Florida | 33462 | — |
| Fort Wayne Cardiology | Fort Wayne | Indiana | 46805 | — |
| Genesis Medical Center | Davenport | Iowa | 52803 | — |
| Michigan Cardiovascular Institute | Saginaw | Michigan | 48601 | — |
| North Shore University Hospital | Manhasset | New York | 11030 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Cleveland Clinic Foundation Department of Hear Failure/Transplantation | Cleveland | Ohio | 44195 | — |
| The Ohio State University Hospital | Columbus | Ohio | 43210 | — |
| The Pavillion at Doylestown Hospital | Doylestown | Pennsylvania | 18901 | — |
| Texas Cardiac Arrhythmia Research | Austin | Texas | 78758 | — |
| Intermountain Medical Center | Salt Lake City | Utah | 84157 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00289276, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2010 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00289276 live on ClinicalTrials.gov.